Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Feb 26, 2024
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- Notice of Information: Modifications to the NIDCR Special Council Review Procedures
(NOT-DE-24-012)
National Institute of Dental and Craniofacial Research
- Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-24-105 and RFA-MH-24-106
(NOT-MH-24-180)
National Institute of Mental Health
- Extension of Application Receipt Date for RFA-OH-24-002 Exploratory/Developmental Grants on Lifestyle Medicine Research Related to the World Trade Center Health Program (R21)
(NOT-OH-24-008)
National Institute for Occupational Safety and Health
- Extension of Application Receipt Date for RFA-OH-24-003 Exploratory/Developmental Grants Related to the World Trade Center Survivors (R21-No Applications with Responders Accepted)
(NOT-OH-24-009)
National Institute for Occupational Safety and Health
- Extension of Application Receipt Dates for RFA-OH-24-004 World Trade Center Health Program Mentored Research Scientist Career Development Award (K01)
(NOT-OH-24-010)
National Institute for Occupational Safety and Health
- Notice of Information: Reissuance of the Suite of Notices of Funding Opportunities (NOFOs) for the National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Awards (CTSA) Program
(NOT-TR-24-008)
National Center for Advancing Translational Sciences
- Request for Information (RFI): Proposed Use of Common Data Elements (CDEs) for NIH-Funded Clinical Research and Trials
(NOT-OD-24-063)
Office of the Director, NIH
Notice of Changes to Funding Opportunities
- Notice of Change to the Application and Submission Information in NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed), PAR-23-109
(NOT-AI-24-033)
National Institute of Allergy and Infectious Diseases
- Notice of Change to Key Dates for PAR-24-062, "Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)"
(NOT-DA-23-053)
National Institute on Drug Abuse
- Notice of Change to the budget limits in RFA-DA-25-047 and RFA-DA-25-048, "Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 and R43/R44 Clinical Trials Optional)"
(NOT-DA-23-067)
National Institute on Drug Abuse
- Notice to Clarify the Eligibility Criteria of Program Directors/Principal Investigators in PAR-22-180 "Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)"
(NOT-GM-24-026)
National Institute of General Medical Sciences
- Notice of NICHD Withdrawal from Participation in PAR-24-043 "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
(NOT-HD-24-005)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of NICHD Withdrawal from Participation in PAR-24-063 " Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
(NOT-HD-24-006)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Change: Additional Receipt Date for PAR-23-098, "Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)"
(NOT-HG-24-015)
National Human Genome Research Institute
- Notice of Early Expiration of RFA-HG-22-026, "Diversity Centers for Genome Research (U54 Clinical Trials Optional)"
(NOT-HG-24-017)
National Human Genome Research Institute
- Notice of Early Expiration of RFA-HG-22-027, "Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)"
(NOT-HG-24-018)
National Human Genome Research Institute
- Notice to Extend the Expiration Date of PAR-21-143, "NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00)"
(NOT-HG-24-019)
National Human Genome Research Institute
- Notice of Change in Key Dates for PAR-23-111, "NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)"
(NOT-MD-24-006)
National Institute on Minority Health and Health Disparities
- Notice of Change in Key Dates for PAR-24-077, "Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)"
(NOT-MD-24-008)
National Institute on Minority Health and Health Disparities
- Notice of Change in Key Dates for PAR-23-309, "Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)"
(NOT-MD-24-009)
National Institute on Minority Health and Health Disparities
- Notice of Change to Foreign Institution Eligibility in PA-23-048 "Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)"
(NOT-OD-24-062)
Office of the Director, NIH
- Notice of Change to Special Areas of Research Interest for PAR-22-233 "Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed)"
(NOT-OD-24-066)
Office of Behavioral and Social Sciences Research
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
(NOT-AR-24-016)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Notice of Intent to Publish a Notice of Funding Opportunity for the Re-Issue of PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional)
(NOT-TR-24-009)
National Center for Advancing Translational Sciences
- Notice of Intent to Publish a Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
(NOT-TR-24-010)
National Center for Advancing Translational Sciences
- Notice of Intent to Publish a Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
(NOT-TR-24-011)
National Center for Advancing Translational Sciences
- Notice of Intent to Publish a Notice of Funding Opportunity for the Re-issue of PAR-21-336 Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
(NOT-TR-24-012)
National Center for Advancing Translational Sciences
- Notice of Intent to Publish a Notice of Funding Opportunity for the Re-issue of PAR-21-339 - Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
(NOT-TR-24-013)
National Center for Advancing Translational Sciences
Notices of Special Interest
- Notice of Special Interest (NOSI): Administrative Supplements for NIA-VA Mentored Physician and Clinical Psychologist Scientist Award in Alzheimers Disease (AD) and AD-Related Dementias (ADRD)
(NOT-AG-23-054)
National Institute on Aging
- Notice of Special Interest (NOSI): Administrative supplements to understand effects of within-group heterogeneity on cancer control outcomes in underrepresented populations
(NOT-CA-24-032)
National Cancer Institute
- Notice of Special Interest (NOSI): Telehealth Research in Cancer Care
(NOT-CA-24-033)
National Cancer Institute
- Notice of Special Interest (NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being
(NOT-OD-24-058)
Office of Disease Prevention
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
Office of Dietary Supplements
Office of Research on Women's Health
- Notice of Special Interest (NOSI): Research supplements to promote workforce diversity and enhance utility and use of Common Fund datasets
(NOT-RM-24-003)
Office of Strategic Coordination (Common Fund)
Funding Opportunities
- Long-Term Effects of Disasters on Healthcare Systems in Populations with Health Disparities (R01- Clinical Trial Optional)
(PAR-24-109)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute on Aging - NIA MSTEM: Advancing Diversity in Aging Research (ADAR) through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed)
(PAR-24-135)
National Institute on Aging - Translational Neural Devices (R61/R33 - Clinical Trial Optional)
(PAR-24-151)
National Institute of Neurological Disorders and Stroke - Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)
(RFA-AG-25-002)
National Institute on Aging
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research - Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trials Optional)
(RFA-DA-25-043)
National Institute on Drug Abuse - BRAIN Initiative: Scaled reagent resources for brain cell type-specific access across vertebrate species (U01 Clinical Trial Not Allowed)
(RFA-MH-25-100)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke - BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed)
(RFA-MH-25-105)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke - INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
(RFA-OD-24-007)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail) or 313-335-2123, or email Ann Ricketts(link sends e-mail) or Lynn Hudachek(link sends e-mail).